NO20030050D0 - Ny <beta>-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den - Google Patents

Ny <beta>-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den

Info

Publication number
NO20030050D0
NO20030050D0 NO20030050A NO20030050A NO20030050D0 NO 20030050 D0 NO20030050 D0 NO 20030050D0 NO 20030050 A NO20030050 A NO 20030050A NO 20030050 A NO20030050 A NO 20030050A NO 20030050 D0 NO20030050 D0 NO 20030050D0
Authority
NO
Norway
Prior art keywords
beta
preparation
new
pharmaceutical compositions
crystalline form
Prior art date
Application number
NO20030050A
Other languages
English (en)
Other versions
NO20030050L (no
NO323446B1 (no
Inventor
Bruno Pfeiffer
Yves-Michel Ginot
Gerard Coquerel
Stephane Beilles
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20030050L publication Critical patent/NO20030050L/no
Publication of NO20030050D0 publication Critical patent/NO20030050D0/no
Publication of NO323446B1 publication Critical patent/NO323446B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20030050A 2000-07-06 2003-01-06 Ny <beta>-krystallinsk form av perindopril tert-butylaminsalt, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den NO323446B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008792A FR2811319B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002168 WO2001087836A1 (fr) 2000-07-06 2001-07-06 Nouvelle forme cristalline $g(b) du sel de tert-butylamine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (3)

Publication Number Publication Date
NO20030050L NO20030050L (no) 2003-01-06
NO20030050D0 true NO20030050D0 (no) 2003-01-06
NO323446B1 NO323446B1 (no) 2007-05-07

Family

ID=8852171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030050A NO323446B1 (no) 2000-07-06 2003-01-06 Ny <beta>-krystallinsk form av perindopril tert-butylaminsalt, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den

Country Status (36)

Country Link
US (2) US20040029813A1 (no)
EP (2) EP1294689B1 (no)
JP (2) JP3592297B2 (no)
KR (1) KR100513571B1 (no)
CN (1) CN1328260C (no)
AP (1) AP1407A (no)
AR (1) AR029571A1 (no)
AT (1) ATE324367T1 (no)
AU (2) AU2001276419B2 (no)
BG (1) BG66131B1 (no)
BR (1) BR0112244A (no)
CA (1) CA2415442C (no)
CZ (1) CZ301765B6 (no)
DE (1) DE60119107T2 (no)
DK (1) DK1294689T3 (no)
EA (1) EA004874B1 (no)
EE (1) EE05285B1 (no)
ES (1) ES2262666T3 (no)
FR (1) FR2811319B1 (no)
GE (1) GEP20043360B (no)
HK (1) HK1058200A1 (no)
HR (2) HRP20030079B8 (no)
HU (1) HU227673B1 (no)
ME (1) ME00440B (no)
MX (1) MXPA02012921A (no)
NO (1) NO323446B1 (no)
NZ (1) NZ523234A (no)
OA (1) OA12305A (no)
PL (1) PL348493A1 (no)
PT (1) PT1294689E (no)
RS (1) RS51717B (no)
SI (1) SI1294689T1 (no)
SK (1) SK286918B6 (no)
UA (1) UA57189C2 (no)
WO (1) WO2001087836A1 (no)
ZA (1) ZA200300024B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
EA008603B1 (ru) * 2003-06-24 2007-06-29 Ле Лаборатуар Сервье Новые кристаллические формы периндоприл эрбумина
JP4677611B2 (ja) 2003-10-21 2011-04-27 レ ラボラトワール セルヴィエ 結晶ペリンドプリルエルブミンの新規な調製方法
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
LT1729739T (lt) * 2004-03-29 2016-11-10 Les Laboratoires Servier Kietos farmacinės kompozicijos gamybos būdas
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
WO2007020009A1 (en) * 2005-08-12 2007-02-22 Sandoz Ag New crystalline form of perindopril erbumine
WO2007020012A1 (en) * 2005-08-12 2007-02-22 Lek Pharmaceuticals D.D. A process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2008050185A2 (en) * 2006-10-26 2008-05-02 Glenmark Pharmaceuticals Limited Novel polymorphs of perindopril erbumine
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
EP2318365B1 (en) * 2008-06-24 2015-08-12 Mylan Laboratories Limited Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN106432042A (zh) * 2015-08-13 2017-02-22 南京华威医药科技开发有限公司 尼达尼布乙磺酸水合物的药物新晶型
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
US20050203165A1 (en) 2005-09-15
EP1294689B1 (fr) 2006-04-26
HUP0102813A3 (en) 2003-12-29
NZ523234A (en) 2005-01-28
JP2003533508A (ja) 2003-11-11
FR2811319A1 (fr) 2002-01-11
EA200300103A1 (ru) 2003-06-26
AR029571A1 (es) 2003-07-02
EE200300002A (et) 2004-08-16
CN1440388A (zh) 2003-09-03
JP3592297B2 (ja) 2004-11-24
EE05285B1 (et) 2010-04-15
HRP20060361A2 (en) 2008-06-30
ME00440B (me) 2011-10-10
BG66131B1 (bg) 2011-06-30
HUP0102813A2 (hu) 2002-03-28
FR2811319B1 (fr) 2002-08-23
CZ301765B6 (cs) 2010-06-16
CA2415442A1 (fr) 2001-11-22
KR20030016368A (ko) 2003-02-26
BR0112244A (pt) 2003-06-24
NO20030050L (no) 2003-01-06
EP1676839A3 (fr) 2006-11-08
ATE324367T1 (de) 2006-05-15
ES2262666T3 (es) 2006-12-01
HRP20030079B1 (en) 2007-12-31
RS51717B (sr) 2011-10-31
GEP20043360B (en) 2004-06-10
NO323446B1 (no) 2007-05-07
HU227673B1 (hu) 2011-11-28
CN1328260C (zh) 2007-07-25
CA2415442C (fr) 2009-01-27
YU100502A (sh) 2003-08-29
PL348493A1 (en) 2002-01-14
DE60119107D1 (de) 2006-06-01
HU0102813D0 (en) 2001-09-28
HRP20030079A2 (en) 2003-04-30
DK1294689T3 (da) 2006-08-28
HRP20060361A8 (en) 2008-07-31
SK1482003A3 (en) 2003-06-03
DE60119107T2 (de) 2006-12-07
MXPA02012921A (es) 2004-07-30
PT1294689E (pt) 2006-07-31
AU7641901A (en) 2001-11-26
WO2001087836A1 (fr) 2001-11-22
JP2005002121A (ja) 2005-01-06
EP1676839A2 (fr) 2006-07-05
HK1058200A1 (en) 2004-05-07
AU2001276419B2 (en) 2006-11-16
KR100513571B1 (ko) 2005-09-09
CZ2003356A3 (cs) 2003-05-14
BG107533A (bg) 2003-11-28
US7259181B2 (en) 2007-08-21
ZA200300024B (en) 2004-02-05
UA57189C2 (uk) 2003-06-16
SK286918B6 (sk) 2009-07-06
SI1294689T1 (sl) 2006-08-31
US20040029813A1 (en) 2004-02-12
EP1294689A1 (fr) 2003-03-26
AP2002002710A0 (en) 2002-12-31
AP1407A (en) 2005-05-30
OA12305A (en) 2003-12-29
EA004874B1 (ru) 2004-08-26
HRP20030079B8 (en) 2008-09-30

Similar Documents

Publication Publication Date Title
NO20030050L (no) Ny &lt;beta&gt;-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den
NO20030051D0 (no) Ny &lt;gamma&gt;-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den
AU2001276420A1 (en) Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
IS5747A (is) Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær
AU2001276419A1 (en) Novel beta crystalline form of perindopril tert- butylamine salt, preparation method and pharmaceutical compositions containing same
EE04779B1 (et) 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0402161A3 (en) Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them
FR2811320B1 (fr) Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
IL161582A0 (en) Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
NO20010957D0 (no) Nye hydratformer av alendronatnatrium, fremgangsmÕter for fremstilling av disse og farmasøytiske preparater derav
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
IS2338B (is) Nýjar morfólínafleiður, aðferð til framleiðslu þeirra og lyfjablöndur sem innihalda þessar afleiður
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
EE05380B1 (et) FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid
HUP0102815A3 (en) New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
SI1266887T1 (sl) Derivati indenoindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
HU1000441D0 (en) Substituted alkylpyridazone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees